Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia-Reference-Cited by-同舟云学术

Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia

Published:2016-08-29 Issue:5 Volume:64 Page:1473-1482
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Gragnani Laura¹,Visentini Marcella²,Fognani Elisa¹,Urraro Teresa¹,De Santis Adriano²,Petraccia Luisa¹,Perez Marie³,Ceccotti Giorgia¹,Colantuono Stefania²,Mitrevski Milica²,Stasi Cristina¹,Del Padre Martina²,Monti Monica¹,Gianni Elena¹,Pulsoni Alessandro⁴,Fiorilli Massimo²,Casato Milvia²,Zignego Anna Linda¹

Affiliation:

1. Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MaSVE), Department of Experimental and Clinical Medicine; University of Florence; Florence Italy

2. Department of Clinical Medicine; Sapienza University of Rome; Rome Italy

3. Istituto Dermopatico Dell'Immacolata IRCCS; Rome Italy

4. Department of Cellular Biotechnologies and Hematology; Sapienza University of Rome; Italy

Funder

Fondazione Roma (to M.V.)

Associazione Italiana per la Ricerca sul Cancro (fellowship to E.F.)

Istituto Toscano Tumori

Ente Cassa di Risparmio di Firenze

Publisher

Wiley

Subject

Hepatology